Tivity Health (NASDAQ:TVTY) was downgraded by stock analysts at TheStreet from a “b” rating to a “c+” rating in a research report issued on Wednesday.
Several other research analysts also recently issued reports on the company. Zacks Investment Research downgraded Tivity Health from a “buy” rating to a “hold” rating in a research note on Thursday. ValuEngine cut Tivity Health from a “sell” rating to a “strong sell” rating in a research report on Monday. Cantor Fitzgerald reduced their price target on Tivity Health from $52.00 to $49.00 and set an “overweight” rating for the company in a research report on Monday, December 17th. Finally, Oppenheimer reduced their price target on Tivity Health from $44.00 to $34.00 and set an “outperform” rating for the company in a research report on Tuesday, December 11th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company. The company has an average rating of “Buy” and an average price target of $42.29.
NASDAQ:TVTY traded up $0.12 during trading hours on Wednesday, hitting $24.93. 963,440 shares of the stock were exchanged, compared to its average volume of 876,363. Tivity Health has a 52-week low of $23.71 and a 52-week high of $44.35. The company has a current ratio of 0.98, a quick ratio of 0.98 and a debt-to-equity ratio of 0.15. The firm has a market cap of $998.20 million, a P/E ratio of 14.84, a price-to-earnings-growth ratio of 0.94 and a beta of 1.24.
In other news, CEO Donato Tramuto sold 35,000 shares of Tivity Health stock in a transaction that occurred on Wednesday, November 7th. The shares were sold at an average price of $38.25, for a total transaction of $1,338,750.00. Following the completion of the sale, the chief executive officer now directly owns 334,743 shares in the company, valued at approximately $12,803,919.75. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Company insiders own 0.73% of the company’s stock.
Several hedge funds have recently bought and sold shares of TVTY. State of Alaska Department of Revenue grew its position in shares of Tivity Health by 5.7% during the 4th quarter. State of Alaska Department of Revenue now owns 13,691 shares of the company’s stock valued at $339,000 after buying an additional 737 shares during the last quarter. Vanguard Group Inc increased its position in Tivity Health by 0.3% during the 3rd quarter. Vanguard Group Inc now owns 5,788,356 shares of the company’s stock valued at $186,095,000 after purchasing an additional 17,212 shares during the period. Marshall Wace LLP acquired a new stake in Tivity Health during the 3rd quarter valued at approximately $6,604,000. Clearbridge Investments LLC increased its position in Tivity Health by 966,500.0% during the 3rd quarter. Clearbridge Investments LLC now owns 386,640 shares of the company’s stock valued at $12,430,000 after purchasing an additional 386,600 shares during the period. Finally, Vanguard Group Inc. increased its position in Tivity Health by 0.3% during the 3rd quarter. Vanguard Group Inc. now owns 5,788,356 shares of the company’s stock valued at $186,095,000 after purchasing an additional 17,212 shares during the period.
Tivity Health Company Profile
Tivity Health, Inc provides fitness and health improvement programs in the United States. The company offers SilverSneakers senior fitness program to the members of Medicare advantage, Medicare supplement, and group retiree plans; and Prime fitness, a fitness facility access program through commercial health plans and employers.
Recommended Story: What impact do institutional investors have on markets?
Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with MarketBeat.com's FREE daily email newsletter.